The multifaceted role of tissue-resident memory T cells

SN Christo, SL Park, SN Mueller… - Annual Review of …, 2024 - annualreviews.org
Regionalized immune surveillance relies on the concerted efforts of diverse memory T cell
populations. Of these, tissue-resident memory T (TRM) cells are strategically positioned in …

ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs

S Otero-Romero, C Lebrun-Frénay… - Multiple Sclerosis …, 2023 - journals.sagepub.com
Background: With the new highly active drugs available for people with multiple sclerosis
(pwMS), vaccination becomes an essential part of the risk management strategy Objective …

Autoimmune encephalitis misdiagnosis in adults

EP Flanagan, MD Geschwind… - JAMA …, 2023 - jamanetwork.com
Importance Autoimmune encephalitis misdiagnosis can lead to harm. Objective To
determine the diseases misdiagnosed as autoimmune encephalitis and potential reasons …

Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study

L Wieske, KPJ van Dam, M Steenhuis… - The Lancet …, 2022 - thelancet.com
Background Disease-specific studies have reported impaired humoral responses after
SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders treated …

Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine–induced antibody and T cell immunity and function

JJ Sabatino Jr, K Mittl, WM Rowles, K McPolin… - JCI …, 2022 - pmc.ncbi.nlm.nih.gov
BACKGROUND Vaccine-elicited adaptive immunity is a prerequisite for control of SARS-
CoV-2 infection. Multiple sclerosis (MS) disease-modifying therapies (DMTs) differentially …

Magnitude of venous or capillary blood-derived SARS-CoV-2-specific T cell response determines COVID-19 immunity

MJ Scurr, G Lippiatt, L Capitani, K Bentley… - Nature …, 2022 - nature.com
T cells specific for SARS-CoV-2 are thought to protect against infection and development of
COVID-19, but direct evidence for this is lacking. Here, we associated whole-blood-based …

[HTML][HTML] Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron …

MP Sormani, I Schiavetti, M Inglese, L Carmisciano… - …, 2022 - thelancet.com
Background In this study we aimed to monitor the risk of breakthrough SARS-CoV-2
infection in patients with MS (pwMS) under different DMTs and to identify correlates of …

Vaccination and immunotherapies in neuroimmunological diseases

A Winkelmann, M Loebermann, M Barnett… - Nature Reviews …, 2022 - nature.com
Neuroimmunological diseases and their treatment compromise the immune system, thereby
increasing the risk of infections and serious illness. Consequently, vaccinations to protect …

Response of COVID-19 vaccination in multiple sclerosis patients following disease-modifying therapies: A meta-analysis

X Wu, L Wang, L Shen, K Tang - EBioMedicine, 2022 - thelancet.com
Background COVID-19 vaccination is recommended for patients with multiple sclerosis
(pwMS), while disease-modifying therapies (DMTs) may influence the efficacy of SARS-CoV …

Humoral and cellular immune responses on SARS-CoV-2 vaccines in patients with anti-CD20 therapies: a systematic review and meta-analysis of 1342 patients

S Schietzel, M Anderegg, A Limacher, A Born… - RMD open, 2022 - rmdopen.bmj.com
Background Immune responses on SARS-CoV-2 vaccination in patients receiving anti-
CD20 therapies are impaired but vary considerably. We conducted a systematic review and …